Welcome to LookChem.com Sign In|Join Free

CAS

  • or

122433-29-8

Post Buying Request

122433-29-8 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

122433-29-8 Usage

General Description

Ethanone, 1-(2-benzoxazolyl)- (9CI) is a chemical compound with the molecular formula C10H7NO2. It is classified as a ketone and contains a benzoxazolyl group. Ethanone, 1-(2-benzoxazolyl)- (9CI) is primarily used as a building block in the synthesis of various organic compounds. It has applications in the pharmaceutical and agrochemical industries, as well as in the production of specialty chemicals. Additionally, it has been studied for its potential biological activities and therapeutic properties. However, due to its potentially hazardous properties, it should be handled and used with caution in a controlled laboratory setting.

Check Digit Verification of cas no

The CAS Registry Mumber 122433-29-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,2,2,4,3 and 3 respectively; the second part has 2 digits, 2 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 122433-29:
(8*1)+(7*2)+(6*2)+(5*4)+(4*3)+(3*3)+(2*2)+(1*9)=88
88 % 10 = 8
So 122433-29-8 is a valid CAS Registry Number.
InChI:InChI=1/C9H7NO2/c1-6(11)9-10-7-4-2-3-5-8(7)12-9/h2-5H,1H3

122433-29-8SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 20, 2017

Revision Date: Aug 20, 2017

1.Identification

1.1 GHS Product identifier

Product name 1-(Benzo[d]oxazol-2-yl)ethanone

1.2 Other means of identification

Product number -
Other names 1-(1,3-benzoxazol-2-yl)ethanone

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:122433-29-8 SDS

122433-29-8Relevant articles and documents

Development of novel NLRP3-XOD dual inhibitors for the treatment of gout

Wang, Weiwei,Pang, Jing,Ha, Eun Hee,Zhou, Mengze,Li, Zhubin,Tian, Sheng,Li, Huanqiu,Hu, Qinghua

, (2020)

Gout is a crystalline-related arthropathy caused by the deposition of monosodium urate (MSU). Acute gouty arthritis is the most common first symptom of gout. Studies have shown that NOD-like receptor protein 3 (NLRP3) inflammasome as pattern recognition r

Method for synthesizing benzoxazole through microwave radiation of benzamide compound in water phase

-

Paragraph 0063, (2019/03/08)

The invention discloses a method for synthesizing benzoxazole through microwave radiation of a benzamide compound in a water phase. The benzamide compound is added into the water phase under the microwave condition to be subjected to a cyclization reaction for generating the benzoxazole under the alkali condition, and the method for preparing the benzoxazole is environmentally friendly, easy and convenient to operate, safe, low in cost and efficient. Compared with the prior art, the method can be applied to a large number of functional groups, the yield is high, the number of by-products is small, and the method is easy to operate, safe, low in cost and environmentally friendly. (Please see the specifications for the formula).

Compositions containing five-membered unsaturated heterocyclic structure of the α, β unsaturated ketone compound and its preparation method and application

-

Paragraph 0212, (2017/07/14)

The invention provides alpha, beta unsaturated ketone compounds containing benzo five-membered unsaturated heterocycle structures as well as a preparation method and an application and use of the compounds. The alpha, beta unsaturated ketone compounds containing the benzo five-membered unsaturated heterocycle structures have the structure of a formula (I). In addition, the invention further provides a method for preparing the compounds and a pharmaceutical composition containing the components as active components. In vitro activity tests show that the compounds provided by the invention show a remarkable inhibiting effect on tumor cells. Therefore, the invention lays a foundation for lucubrating and developing anti-tumor medicines in the future and meanwhile further provides a new technical means for treating tumor diseases.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 122433-29-8